Dividend policy

The Board has adopted a progressive dividend policy, intending to maintain or grow the dividend each year but, recognising that some earnings fluctuations are to be expected, the annual dividend will reflect the Board’s view of the earnings prospects over the entirety of the investment cycle.

The Board’s aim is to continue to strike a balance between the interests of the business, financial creditors and the Company’s shareholders. After providing for investment in the business, supporting the progressive dividend policy and maintaining a strong, investment-grade credit rating, the Board will keep under review potential investment in immediately earnings-accretive, value-enhancing opportunities.

Announcement & payment of dividends

Dividends will normally be paid twice a year, with a greater proportion paid as a second interim.

• First interim: announced with second quarter and half year results and paid in September
• Second interim: announced with fourth quarter and full year results and paid in March

Dividend calculator & history

To calculate the value of your previous dividend payment, please use the dividend calculator.

Exchange rates

Exchange rates used to convert dividend payments, announced in USD, GBP and SEK are based on the rates on the day prior to the dividend announcement.

Dividend questions

Please refer to the dividend FAQ for common questions regarding dividend payments.

Most recent dividend announcement

The Second Interim Dividend for 2025 was announced on 10 February 2026.

The completion of cross-border movements of shares by intermediaries between the London Stock Exchange, Nasdaq Stockholm and the New York Stock Exchange is subject to the receiving broker identifying and confirming such movements. Where a cross-border movement of shares is initiated but not completed by the relevant dividend record date, the dividend in respect of those shares will be received in the originating market on the relevant dividend payment date.

Following the implementation of AstraZeneca’s Listing Harmonisation from 2 February 2026, the American Depositary Receipts facility has been closed.